Introduction
Blood glucose concentration is the most important regulatory stimulus for B-cell insulin secretion. The process of glucose-induced insulin secretion is fully dependent on the metabolism of the sugar in the B-cell. The products of the glucose metabolism, especially adenosine triphosphate (ATP), close the ATP potassium channel (K ATP ), increasing the intracellular potassium concentration that leads to a membrane depolarization [1] . This phenomenon induces the opening of the voltage sensitive calcium channels (VSCC) provoking a rapid increase in calcium influx and in the intracellular calcium concentration [Ca] i that triggers granule exocytosis [2, 3] . On the other hand, the metabolism of glucose in the B-cell also activates several enzymes, particularly phospholipase C (PLC) and adenylate cyclase (AC), which induce an increase in protein kinase C (PKC) and protein kinase A (PKA) activities, respectively [4, 5] . These kinases have an important role in the mechanism of glucose-induced insulin secretion, including opening of the VSCC [6] .
The insulin secretion, however, is complex and several other stimuli interfere in the process of glucose-induced insulin release, including autonomic nervous system effects, circulating metabolites and hormones. Recently, in a series of perfusion experiments with isolated islets, Peschke et al. [7, 8] showed that melatonin inhibits glucose-and forskolininduced insulin secretion. The data indicated that melatonin probably acts on cultivated neonate pancreatic islets by inhibiting AC activity through the pertussis-toxin sensitive G-protein system via Mel 1a receptors [8] . The elegant study of Peschke's group [7] was performed in islets isolated from the pancreas of neonate rats and after an overnight period in culture. The authors did not investigate if melatonin affects glucose metabolism of the pancreatic islets. Also, effect of melatonin on insulin secretion by islets freshly obtained from adult rats remains to be investigated. These points were addressed in the present study.
For this purpose, pancreatic islets were isolated from adult rats and the effect of melatonin (0.1 lM) was immediately tested for its effect on glucose-and forskolininduced insulin secretion, glucose oxidation, and the content of PKA and PKC a-subunits.
Materials and methods

Animals
Male albino rats weighing 150-200 g (45-60 days old) were obtained from the Institute of Biomedical Sciences, University of Sa˜o Paulo, Sa˜o Paulo, Brazil. The animals were kept in groups of five at 23°C in a room with a light/dark cycle of 12/12 hr (lights on at 07:00 hr). Ethics approval was granted for this study by the Institute of Biomedical Sciences, Animal Experimental Committee, University of Sa˜o Paulo, Sa˜o Paulo, Brazil.
Chemicals
Collagenase type V, bovine albumin-fraction V, Tris, phenylmethylsulfonylfluoride (PMSF), aprotinin, dithiothreitol (DTT) and melatonin were purchased from Abstract: The effect of melatonin (0.1 lM) on freshly isolated islets from adult rats was investigated. Melatonin caused a marked decrease of insulin secretion by islets in response to glucose. The mechanism involved was then examined. Melatonin did not interfere with glucose metabolism as indicated by the measurement of glucose oxidation. However, the content of the protein kinase A (PKA) catalytic a-subunit was significantly decreased in islets exposed to melatonin for 1 hr in the presence of 8.3 mM glucose, whereas that of the protein kinase C (PKC) a-subunit remained unchanged. Melatonin also inhibited forskolin-induced insulin secretion, a well known activator of adenylate cyclase (AC) activity. This may explain the low content of insulin found in islets incubated in the presence of melatonin for 3 hr. In fact, 3¢,5¢ -cyclic adenosine monophosphate (cAMP), a product of AC activity, stimulates insulin synthesis. These findings led us to postulate that a down-regulation of the PKA signaling pathway may be the mechanism involved in the melatonin inhibition of the process of glucose-induced insulin secretion.
Sigma Chemical Co. (St Louis, MO, USA). [U-
14 C]-Glucose and 125 I-insulin were obtained from Dupont NEN products (Boston, MA, USA). Rat insulin standards and antirat insulin antibody were a gift from Dr LeclercqMayer, Universite´Libre de Bruxelles, Belgium. The reagents and apparatus for SDS-PAGE and immunoblotting were from Bio-Rad (Richmond, CA, USA). Protein A sepharose 6MB was from Pharmacia (Upsala, Sweden). Polyclonal anti-PKA and anti-PKC antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Insulin secretion during incubation of islets
Rat pancreatic islets were isolated as described by Lacy and Kostianovsky [9] . Incubations of five islets were carried out at 37°C for 60 min in 0.5 mL of Krebs-Henseleit (KH) buffer (Na + 139 mM, K + 5 mM, Ca 2+ 1 mM, Mg 2+ 1 mM, Cl -124 mM, HCO 3 -24 mM) and 0.2% albumin in the presence of glucose(5.6; 8.3 or 16.7 mM). The buffer was equilibrated in a mixture of O 2 (95%) and CO 2 (5%). When indicated, melatonin was added to the medium at 0.1 lM always. At the end of the experiments, the medium was collected for insulin assay. The effect of forskolin, an activator of AC, was tested in the presence of 5.6 mM glucose, by adding 1.0, 5.0 or 7.0 lM of the compound to the medium containing or not melatonin.
Perfusion experiments
The method used was slightly modified from our previous publications [10] . Islets (n ¼ 100) were preincubated for 60 min at 37°C in the presence of 16.7 mM glucose and 0.1 lM melatonin. After this period, the islets were washed five times with KH albuminated buffer and perfused in a chamber containing a special filter (cellulose acetate-SCWP100, 8 lm pore size). The perfusion was performed with KH albuminated buffer at a constant rate of 1 mL/min (Fig. 2) . The perfusion medium was collected at 1-min intervals from the 31st until to the 70th minute using a fraction collector (ULTRORAC II, LKB, BROMA 2070). The composition of the perfusion medium was changed as follows: 5.6 mM glucose only from the 31st to the 40th min, 16.7 mM glucose without (control) or with 0.1 lM melatonin (Mel) from the 41st to 60th minutes and again 5.6 mM glucose only form the 61st to the 70th min. Aliquots of all experiments were frozen and stored at -20°C for insulin assay.
Measurement of [U-
14 C]-glucose decarboxylation
Groups of 30 islets were incubated in glass tubes containing 100 lL of KH albuminated buffer solution, 2 lCi/mL [U-14 C]-glucose and 5.6, 8.3 or 16.7 mM glucose in the presence and absence of 0.1 lM melatonin, equilibrated against a mixture of O 2 (95%) and CO 2 (5%). The tubes were transferred into counting vials that were carefully closed with a rubber stopper and incubated for 120 min in a shaker bath at 37°C. After this period, 0.1 mL of HCl (0.5 N) was added, by syringe, to the tubes containing the islets to stop the reaction, without loss of the gas produced during the experiment. The 14 CO 2 produced was exposed for 2 hr to NaOH solution (1 N) injected outside the tube containing the islets, in the same manner as for HCl. Biodegradable scintillation liquid (Amersham, Pharmacia, Upsala, Sweden) was added and radioactivity of the 14 CO 2 adsorbed by NaOH was counted.
Insulin content of the islets
Batches of 30 islets were incubated for 3 hr at 37°C in the KH buffer containing 8.3 mM glucose in the presence or absence of melatonin 0.1 lM. After incubation, the islets were washed three times with KH buffer, and resuspended in 1 mL KH buffer for sonication. Samples of the experiments were frozen and stored at -20°C for insulin determination.
Determination of the content of PKA and PKC catalytic a-subunit by Western blotting Batches of 100 islets were incubated for 1 hr at 37°C in the KH buffer containing 8.3 mM glucose in the presence or absence of melatonin 0.1 lM. After incubation, 800 lL of ice-cold buffer A (100 mM Tris, 50 mM Hepes, pH 7.4, 100 mM sodium pyrophosphate, 10 mM sodium vanadate, 100 mM sodium fluoride, 1% triton-X-100, 2 mM PMSF and 0.1 mg/mL aprotinin) were transferred to Eppendorf tubes containing the islets, sonicated for cell disruption and centrifuged at 20,000 · g at 4°C for 15 min The protein of the supernatant was measured [11] and used for immunoprecipitation with 10 lL of anti PKA catalytic a-subunit or 10 lL of anti-PKC catalytic a-subunit antibodies and protein A Sepharose 6MB or used as total extracts followed by 8% SDS-PAGE and immunoblot analysis [12] .
Statistical analysis
Results of perfusion experiments, insulin secretion and CO 2 produced are presented as means ± S.E.M. The statistical treatment was carried out using ANOVA. The mean values of incremental integrated areas in perfusion experiments was calculated by subtraction of each point after the 40th minute, until to the end of the experiment, from the mean of the basal values (from the 35th to 40th min). For analysis of the immunoblotting data, Student's unpaired t-test was used. The level of significance was set for P < 0.05.
Results
Progressive increments of glucose concentrations (5.6, 8.3 and 16.7 mM) proportionally raised the amount of insulin released during 60 min incubation by control islets as expected (Fig. 1) . Melatonin caused a marked inhibition of insulin secretion in the presence of all glucose concentrations. The indole also inhibited insulin secretion by pancreatic islets in the perfusion experiments (Fig. 2) . Under these conditions, insulin release by 16.7 mM glucose stimulus was abolished by melatonin (Fig. 2) .
The total content of insulin was determined in pancreatic islets incubated for 3 hr in 8.3 mM glucose in the presence or absence of melatonin (0.1 lM). The indole caused a significant reduction of insulin content (from 9634 ± 258 to 6665 ± 771 lU per islet; mean ± S.E.M. of 10 samples).
The rates of [U-
14
C] -glucose decarboxylation were also measured in islets incubated for 120 min in the presence of increasing glucose concentrations (5.6, 8.3 and 16.7 mM). Melatonin did not cause significant change of [U-
14 C]-glucose decarboxylation (Fig. 3) . This result indicates that glucose metabolism in pancreatic islets is not affected by melatonin and led us to investigate alterations in other important pathways involved in the process of glucoseinduced insulin secretion. The effect of melatonin on forskolin-induced insulin secretion was then examined (Fig. 4) . Forskolin per se caused a significant increase of insulin secretion. This effect of forskolin was abolished by melatonin, especially at 5 and 7 lM concentrations.
The level of of PKA a-subunit was determined and it was significantly decreased in islets exposed for 60 min to 8.3 mM glucose plus melatonin (Fig. 5) . A similar protocol was used to investigate PKC a-subunit levels. In contrast to what was observed for PKA, the level of PKC a-subunit was not changed in islets incubated with melatonin (Fig. 5) .
Discussion
The carbohydrate metabolism is influenced by melatonin both in humans [13] [14] [15] [16] and in rodents [17] [18] [19] . Pinealectomy induces insulin resistance characterized by decreased glucose tolerance and a reduced glycogenesis in liver and muscle of rats [20] [21] [22] . Pinealectomy is followed by a reduction in blood sugar levels, and after alloxan treatment, the blood glucose rise is higher in pinealectomized than in intact rats [23] . Conversely, the infusion of pineal extracts [17] leads to hypoglycemia and increases glucose tolerance and hepatic and muscule glycogenesis after glucose loading. The changes in carbohydrate metabolism are, at least .min )1 ) by perfused islets. The islets were preincubated in the presence of 16.7 mM glucose and 0.1 lM melatonin. During the first 10 min (from 31st to 40th min), the two batches of islets were perfused in the presence of 5.6 mM glucose only. Between the 41st to 60th min, the islets were perfused in the presence of 16.7 mM glucose without (Control) or with (Mel) melatonin. Afterwards, the perfusion of the two batches was carried out again in the presence of 5.6 mM glucose only. The values are presented as mean ± S.E.M. of eight experiments. For details of the experiments see Material and Methods section. partially, caused by the effect of melatonin on insulin levels [18] . Lima et al. [19] have shown that pinealectomized rats exhibit a moderate decrease of plasma glucose and an increase in circulating insulin. Although melatonin clearly controls glucose homeostasis and insulin levels, the action of this indole on glucose-induced insulin secretion is not fully understood.
In the present study, melatonin caused a remarkable decrease of glucose-induced insulin secretion (Fig. 1) during a 60-min incubation in the presence of rising glucose concentrations (5.6, 8.3 and 16.7 mM) . The inhibitory effect of melatonin on insulin secretion became more pronounced with higher glucose concentrations in the medium. To verify in a dynamic and more detailed way the inhibition observed under static conditions, islets were preincubated in the presence of 16.7 mM glucose and with 0.1 lM melatonin being perfused afterwards (Fig. 2) . When melatonin and 16.7 mM glucose were concomitantly added to the medium, insulin secretion was abolished (from the 41st to the 60th min perfusion) in comparison with the islets exposed to 16.7 mM glucose only. These findings confirm the previous observations of the Peschke's group. These authors showed that melatonin decreases insulin secretion induced by pulses of glucose (50 mM) or KCl (100 mM). Their experiments, however, were carried out in islets isolated from neonate rats after being cultivated overnight.
Considering these results, the following question was addressed: does melatonin interfere with glucose metabolism? In the Peschke study [7, 8] , glucose metabolism of the islets was not examined. To answer this question, we evaluated the action of melatonin on [U-
14 C]-glucose decarboxylation by incubated islets. Despite the remarkable inhibitory effect of the indole on glucose induced-insulin secretion, melatonin did not affect glucose metabolism in incubated pancreatic islets (Fig. 3) . This is a surprising observation because the process of glucose-induced insulin secretion is strongly associated with glucose metabolism [24] [25] [26] . The generation of ATP from glucose oxidation closes K ATP channels which are triggered for the complex process of insulin release in pancreatic islets [1] .
Peschke et al. [8] identified Mel 1a receptors in pancreatic islets isolated from neonate rats and showed that melatonin inhibits glucose-and also forskolin-induced insulin secretion. Forskolin is a well known activator of AC and increases the production of 3¢,5¢ -cyclic adenosine monophosphate (cAMP) [27] . The mechanisms by which PKA augments glucose stimulated-insulin release may involve potentiation of glucose-induced Ca 2+ influx by either cAMP-dependent protein phosphorylation of the voltagesensitive Ca 2+ channels or by sensitization of the secretory mechanisms to Ca 2+ , increasing the efficiency of the secretory pathway by reversible phosphorylation [28, 29] . Peschke et al. [8] postulated that melatonin probably acts on overnight-cultivated neonate pancreatic islets by inhibiting the AC/cAMP-system. This possibility was investigated in our experimental model. We incubated isolated islets in the presence of 5.6 mM glucose, in the absence or presence of melatonin and melatonin plus forskolin (Fig. 4) . Confirming Peschke's observations, melatonin inhibited forskolin-induced insulin secretion. To better clarify this point we then carried out experiments to determine the content of PKA a-subunit in islets incubated in the presence of melatonin. The content of PKA was significantly decreased in islets exposed for 60 min to melatonin in the presence of 5.6 mM glucose with no alteration in the content of PKC a-subunit (Fig. 5) . A decreased content of cAMP may explain the lower content of insulin observed in pancreatic islets after 3 hr incubation. In fact, cAMP has been shown to stimulate insulin mRNA transcription rate (30, 3129) .
The results presented herein led us to conclude that 0.1 lM melatonin acutely inhibits insulin secretion by fresh islets isolated from adult rats as reported by Peschke's group for overnight cultivation of neonate islets. This effect is not associated with alteration in B-cell glucose metabolism but with a decrease of PKA content. It remains to be examined, however, if other pathways in the process of insulin release are also affected by melatonin. The proteins from the islets were extracted and processed as described in Materials and Methods. The immunoblotting was performed using anti-PKA and anti-PKC a-subunit antibodies. The PKA and PKC protein levels are shown as means ± S.E.M. of the scanning densitometric analysis of four distinct experiments. *P < 0.05.
